Alfonso E Bello

Summary

Publications

  1. ncbi Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature
    Alfonso E Bello
    University of Illinois College of Medicine at Chicago, Chicago, IL 60612, USA
    Curr Med Res Opin 22:2221-32. 2006
  2. ncbi Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trials
    Jay L Goldstein
    Section of Digestive and Liver Diseases, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612 7323, USA
    J Rheumatol 32:111-7. 2005
  3. ncbi Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis
    Andrew Whelton
    Universal Clinical Research Center, Inc, and The Johns Hopkins University School of Medicine, Baltimore, Maryland 21030 1603, USA
    Am J Cardiol 90:959-63. 2002
  4. ncbi Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study
    Gurkirpal Singh
    Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, Calif 94301, USA
    Am J Med 119:255-66. 2006

Collaborators

Detail Information

Publications4

  1. ncbi Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature
    Alfonso E Bello
    University of Illinois College of Medicine at Chicago, Chicago, IL 60612, USA
    Curr Med Res Opin 22:2221-32. 2006
    ..The demand for treatments, both traditional and non-traditional, will continue to grow as the population ages...
  2. ncbi Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trials
    Jay L Goldstein
    Section of Digestive and Liver Diseases, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612 7323, USA
    J Rheumatol 32:111-7. 2005
    ..To evaluate the relative gastrointestinal (GI) tolerability of celecoxib and rofecoxib in elderly hypertensive patients with osteoarthritis (OA) with or without coadministration of low dose aspirin (ASA) (< or = 325 mg daily)...
  3. ncbi Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis
    Andrew Whelton
    Universal Clinical Research Center, Inc, and The Johns Hopkins University School of Medicine, Baltimore, Maryland 21030 1603, USA
    Am J Cardiol 90:959-63. 2002
    ..7%) compared with the celecoxib group (4.7%) (p <0.05). Thus, in patients with controlled hypertension on a fixed antihypertensive regimen, careful monitoring of BP is warranted after the initiation of celecoxib or rofecoxib therapy...
  4. ncbi Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study
    Gurkirpal Singh
    Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, Calif 94301, USA
    Am J Med 119:255-66. 2006
    ..To evaluate the efficacy and upper gastrointestinal (UGI) safety of celecoxib, compared with nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs), among patients with osteoarthritis...